$HQY
HEALTHEQUITY, INC.

2021 Q3 Form 10-Q Financial Statement

#000142833621000035 Filed on September 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $189.1M $176.0M $190.0M
YoY Change 7.42% 103.22% 118.27%
Cost Of Revenue $77.13M $74.26M $81.94M
YoY Change 3.87% 163.47% 179.66%
Gross Profit $112.0M $101.8M $108.1M
YoY Change 10.01% 74.17% 87.13%
Gross Profit Margin 59.21% 57.82% 56.88%
Selling, General & Admin $38.29M $32.66M $30.45M
YoY Change 17.23% 85.01% 72.26%
% of Gross Profit 34.19% 32.09% 28.18%
Research & Development $37.90M $30.65M $31.08M
YoY Change 23.63% 163.24% 184.99%
% of Gross Profit 33.85% 30.12% 28.76%
Depreciation & Amortization $3.500M $4.100M $27.51M
YoY Change -14.63% 310.0% 476.3%
% of Gross Profit 3.13% 4.03% 25.45%
Operating Expenses $112.8M $92.76M $93.00M
YoY Change 21.66% 176.26% 209.24%
Operating Profit -$875.0K $9.028M $15.07M
YoY Change -109.69% -63.69% -45.55%
Interest Expense $7.254M $8.895M $12.26M
YoY Change -18.45% 13176.12% 19365.08%
% of Operating Profit 98.53% 81.37%
Other Income/Expense, Net -$6.910M -$9.719M -$13.03M
YoY Change -28.9% 761.61% -155.2%
Pretax Income -$7.785M -$691.0K $2.044M
YoY Change 1026.63% -102.91% -96.01%
Income Tax -$4.000M -$543.0K $218.0K
% Of Pretax Income 10.67%
Net Earnings -$3.818M -$148.0K $1.826M
YoY Change 2479.73% -100.76% -95.63%
Net Earnings / Revenue -2.02% -0.08% 0.96%
Basic Earnings Per Share -$0.05 $0.00 $0.03
Diluted Earnings Per Share -$0.05 $0.00 $0.03
COMMON SHARES
Basic Shares Outstanding 83.48M shares 72.34M shares 70.98M shares
Diluted Shares Outstanding 83.48M shares 72.34M shares 72.29M shares

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $753.8M $268.9M $171.1M
YoY Change 180.31% -67.01% -48.04%
Cash & Equivalents $753.8M $268.9M $171.1M
Short-Term Investments
Other Short-Term Assets $32.64M $43.98M $42.90M
YoY Change -25.79% 299.87% 420.39%
Inventory
Prepaid Expenses
Receivables $74.22M $70.24M $69.79M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $860.6M $383.1M $283.8M
YoY Change 124.63% -55.11% -22.16%
LONG-TERM ASSETS
Property, Plant & Equipment $27.38M $34.53M $35.82M
YoY Change -20.7% 249.72% 322.37%
Goodwill $1.364B $1.334B $1.333B
YoY Change 2.23% 28577.88% 28552.57%
Intangibles $770.3M $783.1M $777.5M
YoY Change -1.63% 782.19% 854.7%
Long-Term Investments
YoY Change
Other Assets $42.97M $34.66M $35.17M
YoY Change 23.99% 55.34% 63.49%
Total Long-Term Assets $2.288B $2.281B $2.279B
YoY Change 0.3% 831.79% 881.93%
TOTAL ASSETS
Total Short-Term Assets $860.6M $383.1M $283.8M
Total Long-Term Assets $2.288B $2.281B $2.279B
Total Assets $3.149B $2.664B $2.562B
YoY Change 18.18% 142.58% 329.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.696M $11.71M $7.338M
YoY Change -59.89% 327.3% 273.63%
Accrued Expenses $49.10M $37.42M $39.99M
YoY Change 31.19% 92.99% 338.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $78.13M $54.69M $46.88M
YoY Change 42.86%
Total Short-Term Liabilities $185.1M $153.8M $134.6M
YoY Change 20.39% 314.03% 475.78%
LONG-TERM LIABILITIES
Long-Term Debt $895.4M $952.9M $1.167B
YoY Change -6.03%
Other Long-Term Liabilities $20.09M $8.210M $3.783M
YoY Change 144.71% 1017.01% 877.52%
Total Long-Term Liabilities $1.101B $1.170B $1.387B
YoY Change -5.93% 159120.27% 358355.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $185.1M $153.8M $134.6M
Total Long-Term Liabilities $1.101B $1.170B $1.387B
Total Liabilities $1.286B $1.324B $1.522B
YoY Change -2.88% 1528.41% 2159.92%
SHAREHOLDERS EQUITY
Retained Earnings $213.9M $213.2M $213.3M
YoY Change 0.34% -8.52% -0.16%
Common Stock $8.000K $8.000K $7.000K
YoY Change 0.0% 14.29% 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.863B $1.340B $1.041B
YoY Change
Total Liabilities & Shareholders Equity $3.149B $2.664B $2.562B
YoY Change 18.18% 142.58% 329.49%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$3.818M -$148.0K $1.826M
YoY Change 2479.73% -100.76% -95.63%
Depreciation, Depletion And Amortization $3.500M $4.100M $27.51M
YoY Change -14.63% 310.0% 476.3%
Cash From Operating Activities $37.25M $53.70M $15.03M
YoY Change -30.64% 70.48% -40.69%
INVESTING ACTIVITIES
Capital Expenditures -$22.83M -$30.40M $7.511M
YoY Change -24.89% 347.06% 567.05%
Acquisitions $0.00
YoY Change
Other Investing Activities $2.367M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$20.47M -$30.40M -$25.29M
YoY Change -32.67% 340.58% -59.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $7.812M
YoY Change
Cash From Financing Activities 200.0K 74.60M -$10.37M
YoY Change -99.73% -83.82% -345.09%
NET CHANGE
Cash From Operating Activities 37.25M 53.70M $15.03M
Cash From Investing Activities -20.47M -30.40M -$25.29M
Cash From Financing Activities 200.0K 74.60M -$10.37M
Net Change In Cash 16.98M 97.90M -$20.63M
YoY Change -82.65% -79.85% -35.85%
FREE CASH FLOW
Cash From Operating Activities $37.25M $53.70M $15.03M
Capital Expenditures -$22.83M -$30.40M $7.511M
Free Cash Flow $60.08M $84.10M $7.515M
YoY Change -28.56% 119.58% -68.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001428336
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Document Period End Date
DocumentPeriodEndDate
2021-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36568
dei Entity Registrant Name
EntityRegistrantName
HEALTHEQUITY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2383166
dei Entity Address Address Line1
EntityAddressAddressLine1
15 West Scenic Pointe Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Draper,
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84020
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
727-1000
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
HQY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
83508975 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
753754000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
328803000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5824000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4239000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74223000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
72767000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
32637000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
58607000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
860614000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
460177000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27382000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29106000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
83768000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
89508000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
770329000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
767003000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
1363568000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
1327193000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42973000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37420000 USD
CY2021Q3 us-gaap Assets
Assets
3148634000 USD
CY2021Q1 us-gaap Assets
Assets
2710407000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4696000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1614000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
40154000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50670000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49098000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20091000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8808000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75880000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
78125000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
62500000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13051000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14037000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
185124000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
204701000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
895449000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
924217000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
69998000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74224000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
115306000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
119729000 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1100844000 USD
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1126978000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1285968000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1331679000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
83608000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83608000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77168000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77168000 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1648743000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1158372000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
213915000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
220348000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1862666000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
158218000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
156192000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1378728000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3148634000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2710407000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189103000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176039000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
373305000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
366050000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77132000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
74255000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
111971000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
101784000 USD
us-gaap Gross Profit
GrossProfit
215087000 USD
us-gaap Gross Profit
GrossProfit
209858000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15476000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12167000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29562000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23622000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37898000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30654000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73367000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61732000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22812000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20493000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43499000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39491000 USD
CY2021Q3 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
20289000 USD
CY2020Q3 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
19077000 USD
hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
40103000 USD
hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
37779000 USD
CY2021Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
16371000 USD
CY2020Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
10365000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
25178000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
23135000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
112846000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
92756000 USD
us-gaap Operating Expenses
OperatingExpenses
211709000 USD
us-gaap Operating Expenses
OperatingExpenses
185759000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-875000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9028000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3378000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
24099000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
7254000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
8895000 USD
us-gaap Interest Expense
InterestExpense
13943000 USD
us-gaap Interest Expense
InterestExpense
21158000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
344000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-543000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7418000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-824000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3286000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1588000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6910000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9719000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17229000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22746000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7785000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-691000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13851000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1353000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3967000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-325000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3818000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3818000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71669000 shares
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-148000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-148000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6433000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6433000 USD
us-gaap Net Income Loss
NetIncomeLoss
1678000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1678000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83481000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72343000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82628000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83481000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72343000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82628000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72971000 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1848270000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1040650000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1378728000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1862666000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1340336000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1862666000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1340336000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6433000 USD
us-gaap Net Income Loss
NetIncomeLoss
1678000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64819000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56106000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
28416000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18834000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2482000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2533000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1011000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
752000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1145000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4051000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-568000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
230000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-628000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-20636000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3187000 USD
hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-6060000 USD
hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-5563000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-10639000 USD
us-gaap Payments For Software
PaymentsForSoftware
32097000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13854000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-30213000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30000 USD
hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-4556000 USD
hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-5723000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
1616000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
5477000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68166000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68662000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
49533000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments For Software
PaymentsForSoftware
21787000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6352000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8987000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2653000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24922000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55696000 USD
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
2367000 USD
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88268000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
456642000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
287318000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15625000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
215625000 USD
hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
2636000 USD
hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
10292000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6672000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2817000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
445053000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64218000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
424951000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
77184000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328803000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191726000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
753754000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-5545000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
798000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
357000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268910000 USD
us-gaap Interest Paid Net
InterestPaidNet
9838000 USD
us-gaap Interest Paid Net
InterestPaidNet
17659000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1104000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
8147000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
119000 USD
hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
66000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1177000 USD
hqy Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
0 USD
hqy Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
540000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3818000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-148000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6433000 USD
us-gaap Net Income Loss
NetIncomeLoss
1678000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83481000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72343000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82628000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71669000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83481000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72343000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82628000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71669000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1302000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83481000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72343000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82628000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72971000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36163000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30987000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63545000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60093000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27382000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29106000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
3500000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
4100000 USD
us-gaap Depreciation
Depreciation
7400000 USD
us-gaap Depreciation
Depreciation
8000000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4000000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4100000 USD
hqy Contract With Customer Recognition Term Interchange Arrangement
ContractWithCustomerRecognitionTermInterchangeArrangement
P10Y
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1100000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
3498000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
3925000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
7809000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
8249000 USD
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
450000 USD
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
450000 USD
us-gaap Sublease Income
SubleaseIncome
900000 USD
us-gaap Sublease Income
SubleaseIncome
900000 USD
CY2021Q3 us-gaap Lease Cost
LeaseCost
3048000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
3475000 USD
us-gaap Lease Cost
LeaseCost
6909000 USD
us-gaap Lease Cost
LeaseCost
7349000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-824000 USD
CY2021Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
533000 USD
CY2020Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
76000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
941000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
676000 USD
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1665000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-28000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7604000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
66000 USD
CY2021Q3 hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
1476000 USD
CY2020Q3 hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
-928000 USD
hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
3377000 USD
hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
-2198000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
344000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3286000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1588000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
7261000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
6468000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
320000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
17480000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1023434000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
962752000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
253105000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
195749000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
770329000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
767003000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29500000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
57400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48100000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
36400000 USD
CY2021Q2 hqy Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
63100000 USD
CY2021Q2 hqy Lessee Operating Lease Lease Not Yet Commenced Undiscounted Term
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedTerm
P11Y
CY2021Q2 hqy Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
63100000 USD
CY2021Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
30000000 USD
CY2018Q3 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2018Q2 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7400000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.508
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.536
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.786
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.240
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.256
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.289
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.629
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28758000 USD
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.574
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10700000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10200000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9900000 USD
CY2021Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0237
hqy Debt Instrument Covenant Description Acquisition Threshold For Maximum Total Net Leverage Ratio
DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio
100000000 USD
CY2021Q3 hqy Debt Instrument Covenant Description Interest Coverage Ratio
DebtInstrumentCovenantDescriptionInterestCoverageRatio
3.00
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15617000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11438000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18834000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1674000 shares
CY2021Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
1.25
CY2021Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.46
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
87164000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
225000 shares
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
1.25
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
44.53
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
23.69
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1449000 shares
CY2021Q3 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
1.25
CY2021Q3 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
60083000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1449000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
32.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
60083000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1352000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.95
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
59645000 USD

Files In Submission

Name View Source Status
0001428336-21-000035-index-headers.html Edgar Link pending
0001428336-21-000035-index.html Edgar Link pending
0001428336-21-000035.txt Edgar Link pending
0001428336-21-000035-xbrl.zip Edgar Link pending
exhibit311-ceo302xfy22q2.htm Edgar Link pending
exhibit312-cfo302xfy22q2.htm Edgar Link pending
exhibit321-ceo906xfy22q2.htm Edgar Link pending
exhibit322-cfo906xfy22q2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hqy-20210731.htm Edgar Link pending
hqy-20210731.xsd Edgar Link pending
hqy-20210731_cal.xml Edgar Link unprocessable
hqy-20210731_def.xml Edgar Link unprocessable
hqy-20210731_htm.xml Edgar Link completed
hqy-20210731_lab.xml Edgar Link unprocessable
hqy-20210731_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending